Myelo Therapeutics GmbH
1 clinical trials · Sponsor
◉ Watch Myelo Therapeutics GmbH
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia (NCT02692742) | Myelo Therapeutics GmbH | 2016-03-01 |
Track Myelo Therapeutics GmbH automatically
Every clearance here is in the API, with alerts when new ones post.